vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $44.3M, roughly 1.0× FIRST BUSINESS FINANCIAL SERVICES, INC.). FIRST BUSINESS FINANCIAL SERVICES, INC. runs the higher net margin — 27.5% vs -19.9%, a 47.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 8.5%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 8.0%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

ABCL vs FBIZ — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.0× larger
ABCL
$44.9M
$44.3M
FBIZ
Growing faster (revenue YoY)
ABCL
ABCL
+779.9% gap
ABCL
788.4%
8.5%
FBIZ
Higher net margin
FBIZ
FBIZ
47.5% more per $
FBIZ
27.5%
-19.9%
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
8.0%
FBIZ

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABCL
ABCL
FBIZ
FBIZ
Revenue
$44.9M
$44.3M
Net Profit
$-8.9M
$12.2M
Gross Margin
Operating Margin
-63.7%
Net Margin
-19.9%
27.5%
Revenue YoY
788.4%
8.5%
Net Profit YoY
73.9%
9.2%
EPS (diluted)
$-0.03
$1.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
FBIZ
FBIZ
Q1 26
$44.3M
Q4 25
$44.9M
$42.2M
Q3 25
$9.0M
$44.5M
Q2 25
$17.1M
$41.0M
Q1 25
$4.2M
$40.8M
Q4 24
$5.0M
$41.2M
Q3 24
$6.5M
$38.1M
Q2 24
$7.3M
$38.0M
Net Profit
ABCL
ABCL
FBIZ
FBIZ
Q1 26
$12.2M
Q4 25
$-8.9M
$13.3M
Q3 25
$-57.1M
$14.4M
Q2 25
$-34.7M
$11.4M
Q1 25
$-45.6M
$11.2M
Q4 24
$14.4M
Q3 24
$-51.1M
$10.5M
Q2 24
$-36.9M
$10.5M
Operating Margin
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
-63.7%
38.5%
Q3 25
-851.8%
39.0%
Q2 25
-290.2%
32.6%
Q1 25
-1479.6%
33.0%
Q4 24
37.2%
Q3 24
-1439.4%
33.8%
Q2 24
-1276.2%
32.6%
Net Margin
ABCL
ABCL
FBIZ
FBIZ
Q1 26
27.5%
Q4 25
-19.9%
31.6%
Q3 25
-637.8%
32.3%
Q2 25
-203.3%
27.8%
Q1 25
-1077.2%
27.4%
Q4 24
35.0%
Q3 24
-785.4%
27.6%
Q2 24
-504.3%
27.5%
EPS (diluted)
ABCL
ABCL
FBIZ
FBIZ
Q1 26
$1.44
Q4 25
$-0.03
$1.57
Q3 25
$-0.19
$1.70
Q2 25
$-0.12
$1.35
Q1 25
$-0.15
$1.32
Q4 24
$1.69
Q3 24
$-0.17
$1.24
Q2 24
$-0.13
$1.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
FBIZ
FBIZ
Cash + ST InvestmentsLiquidity on hand
$128.5M
$265.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
Total Assets
$1.4B
$4.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
FBIZ
FBIZ
Q1 26
$265.8M
Q4 25
$128.5M
$39.5M
Q3 25
$83.2M
$44.3M
Q2 25
$92.4M
$123.2M
Q1 25
$159.3M
$170.6M
Q4 24
$156.3M
$157.7M
Q3 24
$126.6M
$132.0M
Q2 24
$148.3M
$81.1M
Stockholders' Equity
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
$966.9M
$371.6M
Q3 25
$964.0M
$358.3M
Q2 25
$1.0B
$344.8M
Q1 25
$1.0B
$336.1M
Q4 24
$1.1B
$328.6M
Q3 24
$1.1B
$312.0M
Q2 24
$1.1B
$305.2M
Total Assets
ABCL
ABCL
FBIZ
FBIZ
Q1 26
$4.3B
Q4 25
$1.4B
$4.1B
Q3 25
$1.4B
$4.0B
Q2 25
$1.4B
$4.0B
Q1 25
$1.3B
$3.9B
Q4 24
$1.4B
$3.9B
Q3 24
$1.4B
$3.7B
Q2 24
$1.4B
$3.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
FBIZ
FBIZ
Operating Cash FlowLast quarter
$-34.7M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
$-34.7M
$61.7M
Q3 25
$-52.6M
$18.4M
Q2 25
$-32.4M
$15.8M
Q1 25
$-11.6M
$11.3M
Q4 24
$-108.6M
$57.5M
Q3 24
$-28.9M
$13.8M
Q2 24
$-30.0M
$13.1M
Free Cash Flow
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
$-44.6M
$61.1M
Q3 25
$-61.5M
$18.3M
Q2 25
$-45.8M
$15.5M
Q1 25
$-22.2M
$11.2M
Q4 24
$-187.0M
$57.3M
Q3 24
$-47.4M
$13.2M
Q2 24
$-50.1M
$12.7M
FCF Margin
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
-99.4%
144.7%
Q3 25
-687.0%
41.0%
Q2 25
-267.9%
37.8%
Q1 25
-524.0%
27.5%
Q4 24
-3702.8%
139.2%
Q3 24
-728.4%
34.6%
Q2 24
-683.8%
33.3%
Capex Intensity
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
21.9%
1.4%
Q3 25
99.7%
0.3%
Q2 25
78.2%
0.8%
Q1 25
251.1%
0.2%
Q4 24
1552.7%
0.5%
Q3 24
284.6%
1.6%
Q2 24
274.6%
1.1%
Cash Conversion
ABCL
ABCL
FBIZ
FBIZ
Q1 26
Q4 25
4.63×
Q3 25
1.28×
Q2 25
1.39×
Q1 25
1.01×
Q4 24
3.99×
Q3 24
1.31×
Q2 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons